SYDNEY: Biome Australia Limited (ASX: BIO) has successfully launched its newest condition-specific live biotherapeutic product, Biome Acne Probiotic, following the completion of an independent clinical study in February. The result of the study demonstrated that the Biome Acne probiotic strains reduced the number of acne lesions by 31.11% in just four weeks, which was statistically…